AstraZeneca-Ionis drug fails to meet main goal in late-stage heart disease trial
AstraZeneca-Ionis drug fails to meet main goal in late-stage heart disease trial July 9 (Reuters) - AstraZeneca AZN.L said on Thursday that its drug Wainua, made in partnership with Ionis IONS.O, failed to meet the main goal of reducing cardiovascular deaths and recurring heart problems in a late-stage trial.
(Reporting by Raechel Thankam Job in Bengaluru; Editing by Janane Venkatraman)
Recent news on AstraZeneca
See all newsUK Stocks-Factors to watch on July 10 (updated)
UK Stocks-Factors to watch on July 10
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight (updated)
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight
UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains